Cover [Abstract]
Entity Registrant Name
Entity Central Index Key
Document Type
Amendment Flag
Entity Small Business
Amendment Description
Entity Emerging Growth Company
Entity Filer Category
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Address Address Line 1
Entity Address City Or Town
Entity Address State Or Province
Entity Address Postal Zip Code
City Area Code
Local Phone Number
Condensed Consolidated Balance Sheets
Assets
Current assets:
Cash and cash equivalents
Inventory
Other current assets
Total current assets
[Assets, Current]
Intangible assets, net
Property and equipment, net
Intangible Assets, Net
Other assets
Total assets
[Assets]
Liabilities And Stockholders' Equity (deficit)
Current Liabilities:
Notes payable
Payables - related party
Convertible notes payable
Accrued expenses and others current liabilities
Total current liabilities
[Liabilities, Current]
Long term liabilities:
Convertible notes payable - noncurrent
Operating lease liabilities - noncurrent
Total long term liabilities
Total liabilities
[Liabilities]
Stockholders' Equity (deficit)
Preferred stock, $0.01 par value; 10,000,000 shares authorized; none issued
Common stock, $0.01 par value; 300,000,000 shares authorized as of March 31, 2022 and December 31, 2021; 144,379,308 shares issued and outstanding as of March 31, 2022 and December 31, 2021
Additional paid-in capital
Operating Lease Liabilities- Non-current
Accumulated deficit
Translation adjustment
Total stockholders' equity
[Stockholders' Equity Attributable to Parent]
Total liabilities and stockholders' equity
[Liabilities and Equity]
Preferred Stock, Par Value (in Dollars Per Share)
Preferred Stock, Shares Authorized (in Shares)
Preferred Stock, Shares Issued (in Shares)
Preferred Stock, Shares Outstanding (in Shares)
Common Stock, Par Value (in Dollars Per Share)
Common Stock, Shares Authorized (in Shares)
Common Stock, Shares Issued (in Shares)
Common Stock, Shares Outstanding (in Shares)
Condensed Consolidated Statements of Operations (Unaudited)
Revenues
Cost Of Revenues
[Cost of Revenue]
Gross Margin
[Gross Profit]
Operating Expenses:
Research And Development Expenses
Selling, General And Administrative Expenses
Total Operating Expenses
[Operating Expenses]
Operating loss
Non-operating income and expenses, net
Interest expenses, net
[Interest Expense]
Other losses
[Other Expenses]
Total non-operating income and expenses, net
Net loss
Basic and diluted net loss per average share available to common shareholders
Weighted average common shares outstanding- basic and diluted
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
Net loss
Other comprehensive loss:
Translation adjustment
[Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax]
Comprehensive loss
[Comprehensive Income (Loss), Net of Tax, Attributable to Parent]
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)
Statement [Table]
Statement [Line Items]
Equity Components [Axis]
Common Stock
Common Stock [Member]
Preferred Stock
Preferred Stock [Member]
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Translation Adjustment
[Translation Adjustment]
Other comprehensive loss [Member]
Balance, Amount
Balance, Shares
[Shares, Issued]
Issuance Of Stock For Compensation, Shares
Issuance Of Stock For Compensation, Amount
Net loss
Issuance Of Stock For Cash, Shares
Share-based compensation
Translation Adjustment
[Translation Adjustment 1]
Conversion Of Convertible Notes Into Common Stock, Shares
Conversion Of Convertible Notes Into Common Stock, Amount
Issuance Of Common Stock For Intangible Assets, Shares
Issuance Of Stock For Options, Shares
Acquisition Of Intangible Assets And Equipment
[Payments to Acquire Intangible Assets]
Balance, Amount
Balance, Shares
Condensed Consolidated Statements of Cash Flows (Unaudited)
Cash flows from operating activities:
Net Loss
[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]
Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities:
Depreciation And Amortization
Share-based Compensation Expense
Stock Issued For Compensation
Share-based compensation expense
Loss On Disposal Of Property, Plant And Equipment
[Gain (Loss) on Disposition of Property Plant Equipment]
Contract Liabilities
Changes In Operating Assets And Liabilities:
Inventory
[Increase (Decrease) in Inventories]
Other current assets
[Increase (Decrease) in Other Current Assets]
Accrued expenses and others current liabilities
[Increase (Decrease) in Other Current Liabilities]
Prepaid Expense And Other Current Assets
[Increase (Decrease) in Prepaid Expense and Other Assets]
Accounts Payable And Accrued Expenses
Acquisition of property and equipment
[Payments to Acquire Other Property, Plant, and Equipment]
Net cash used in operating activities
[Net Cash Provided by (Used in) Operating Activities]
Cash Flows From Investing Activities :
Proceeds from convertible notes payable
Patent Purchases
[Patent Purchases]
Proceeds from notes payable
Acquisition Of Property, Plant And Equipment
[Payments to Acquire Property, Plant, and Equipment]
Net cash used in investing activities
[Net Cash Provided by (Used in) Investing Activities]
Payments of other notes payable
[Repayments of Notes Payable]
Increase In Refundable Deposits And Others
[Increase In Refundable Deposits And Others]
Payments of lease liabilities
Cash Flows From Financing Activities :
Proceeds From Convertible Note Payable - Related Party
Payments Of Other Note Payable
Proceeds From Exercise Of Stock Options
Payments Of Lease Liabilities
Issuance of convertible notes for payables - related party
Receivable of convertible notes issued
Net change in equipment payable
Net cash provided by financing activities
[Net Cash Provided by (Used in) Financing Activities]
Effect from foreign currency exchange
Net change in cash
Cash And Cash Equivalents At Beginning Of Period
Cash and cash equivalents at end of period
Supplemental Disclosures Of Noncash Financing And Investing Activities:
Cash Paid For Interest
Stock Issued For Subscription
Stock Issued For Patent Cost And Accrued Liabilities
Conversion Of Convertible Notes And Accrued Interest Into Common Stock
Rou Leased Assets
Acquisition Of Intangible Assets And Equipment
[Acquisition Of Intangible Assets And Equipment]
Decrease Of Additional Paid In Capital
Issuance Of Common Stock And Increase Of Current Liability
Organization and Business.
1. Organization and Business
Organization and Summary of Significant Accounting Policies
Organization And Summary Of Significant Accounting Policies
Basis of presentation
2. Basis of presentation
Property, Equipment, net
Property, Equipment And Software, Net
Patents, net
Patents, Net
Convertible Notes Payable
Convertible Notes Payable
Debt Disclosure [Text Block]
Financial Condition
3. Financial Condition
Non-Current Convertible Notes Payable
7.Non-Current Convertible Notes Payable
Related Party Transactions
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Common Stock
Common Stock
Stockholders' Equity Note Disclosure [Text Block]
Preferred Stock
[Preferred Stock]
Stock Option and Stock Plans
Stock Option And Stock Plans
6.Current Convertible Notes Payable and Other Related Party Notes Payable
Warrants
Warrants
[Warrants]
Income Taxes
Income Taxes
Income Tax Disclosure [Text Block]
Commitments and Contingencies
Commitments And Contingencies
Subsequent Events
Subsequent Events
Subsequent Events [Text Block]
Organization And Business
Basis Of Accounting
Fair Value Of Financial Instruments
Going Concern
Stock-based Compensation
Cash And Cash Equivalents
Revenue Recognition
Allowance For Doubtful Accounts
Inventory
Inventory, Policy [Policy Text Block]
Property And Equipment
Patents And Patent Expenditures
Income Taxes
Income Tax, Policy [Policy Text Block]
Research And Development
Use Of Estimates
Basic And Diluted Net Income (loss) Per Share
Concentration Of Credit Risk
Recent Accounting Pronouncements
Property, Equipment And Software
Patents
Estimated Future Amortization Expense
Convertible Notes Payable
Convertible Debt [Table Text Block]
Convertible Notes Payable
Deferred Tax Assets And Liabilities
Equity Compensation Plan Information
Schedule Of List Of Related Parties
Plan Name [Axis]
Upper [Member]
Lower [Member]
Recurring Losses
Exceed Federally Insured Limit
Insured Limit, Per Account
Finite Lived Intangible Asset Use Ful Life
Long-Lived Tangible Asset [Axis]
Furniture and Equipment [Member]
Machinery and Equipment [Member]
Construction in Progress [Member]
Property, Equipment, Gross
Less: Accumulated Depreciation
[Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment]
Property, Equipment, Net
Depreciation Expense
Property, Equipment, Net
Acquired Of Machinery And Equipment From Ainos Ky Pursuant
Patents
[Finite-Lived Intangible Assets, Gross]
Less: Accumulated Amortization
[Finite-Lived Intangible Assets, Accumulated Amortization]
Patents, Net
[Finite-Lived Intangible Assets, Net]
2022
2023
2024
2025
2026
Thereafter
Total Expense
Finite-Lived Intangible Assets by Major Class [Axis]
Patents [Member]
Amortization Expense
Title of Individual [Axis]
Related Party Transaction [Axis]
Related Party [Axis]
Dr. Stephen T. Chen [Member]
1.16 [Member]
2.16 [Member]
3.19 [Member]
4.19 [Member]
6.20 [Member]
7.20 [Member]
10.21 [Member]
11.21 [Member]
Ainos KY [Member]
12.21 [Member]
13.21 [Member]
14.21 [Member]
15.21 [Member]
16.21 [Member]
17.21 [Member]
18.21 [Member]
19.21 [Member]
20.21 [Member]
i2China Management Group LLC [Member]
5.19 [Member]
8a.20 [Member]
8b.20 [Member]
11.21 [Member]
[11.21 [Member]]
Total [Member]
21.21 [Member]
22.21[Member]
23.21[Member]
24.21[Member]
9.21 [Member]
StephenChen
i2 China
8b.20 [Member]
[8b.20 [Member]]
Total Convertible And Non-convertible
Total Convertible And Non-convertible Addition
Total Convertible And Non-convertible Payment
Total Convertible And Non-convertible Accrued
Accrued Interest
Due Date
Annual Interest Rate, From Effective
Effective Date
Unpaid Principal Balance
Conversion Rate
Payment
Annual Interest Rate, Following Maturity
Convertible Rate
Addition
Conversion Note
Due Date
[Due Date]
Convertable Rate
Payment
[Payment]
Convertible And Other Notes Payable- Related Parties
[Convertible And Other Notes Payable- Related Parties]
Payment Related Party
Addition Related Party
Accrued Interest Related Party
Addition
[Addition]
Convertible And Other Notes Payable- Related Parties
[Convertible And Other Notes Payable- Related Parties 1]
Accrued Interest- Related Parties
Payment
[Payment 1]
Accrued Interest
[Accrued Interest]
Annual Interest Rate Following
Annual Interest Rate From,effective
Convertable Rate
[Convertable Rate]
Effective Date
[Effective Date]
Addition
[Addition 1]
Notes Payable- Non-related Party
Notes Payable- Non-related Accrued
Total Notes Payable
Total Notes Payable Addition
Total Notes Payable Payment
Total Notes Payable Accruel
Convertible And Other Notes Payable- Related Parties
Payment- Related Parties
Dr. Stephen T
Ainos KY [Member]
Accrued Interest
Total Convertible And Other Notes Payable
Notes Payable For Related Parties
Total Principal And Accrued Interest Amount
Conversion Price Per Shares
Interest Waived
Repayment Of Debt
Interest Expense
Received Funding
Dr. Stephen T. Chen [Member]
ASE Technology Holding [Member]
Ainos, Inc. (Cayman Island) [Member]
Taiwan Carbon Nano Technology Corporation ("TCNT") [Member]
Name Of The Related Party
Relationship
Description
Non convertible notes payable
Covid-19 Antigen Rapid Test Kits
Principal amount
Development expenses
Purchase price
accrued payable
Convertible notes
Total Assets
Total Assets Percentage
Capital Stock Holding Percentage
Outstanding Capital Stock Percentage
Common Stock Shares Issued
Common Stock Shares Issued Price Per Share
Common Stock Shares Authorized
Issued And Outstanding Shares Of Common Stock Ownership Percentage
Inventory
[Inventory, Net]
Product Development Expenses
Account Payable
Common Stock (Details Narrative))
Class of Stock [Axis]
Counterparty Name [Axis]
StephenChen
Common Stocks [Member]
Bernard Cohen [Member]
Lawrence Lin [Member]
John Junyong Lee [Member]
Chen Agreement [Member]
Ya-Ju [Member]
Daniel Fisher [Member]
Calibre Corporation [Member]
i2China Management Group LLC [Member]
[i2China Management Group LLC [Member]]
Common Stock, Shares Outstanding And Reserved
Reserved For Conversion Of Convertible Debt To Stock
Future Exercise Of Stock Options
Shares Reserved For Warrant Conversion
Common Stock, Capital Shares Reserved For Future Issuance
RSUs for non-employee directors
Common Stock, Shares Authorized
Common Stock, Shares, Issued, Total
Shares Issued, Price Per Share
Proceed From Issuance Of Common Stock
Aggregate Principal And Accrued Interest Amount
Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized
Preferred Stock, Shares Issued
Preferred Stock, Shares Outstanding
Amarillo Biosciences, Inc., 2018 Employee Stock Option Plan
Amarillo Biosciences, Inc., 2018 Officers, Directors, Employees, and Consultants Nonqualified Stock Option Plan
Issue Date Range
Total Shares Authorized
Shares Issued
Share Remaining
Qualified
Nonqualified
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Expired Or Forfeited
Weighted Average Exercise Price Outstanding, Ending
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]
Weighted Average Exercise Price Vested
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price]
Weighted Average Remaining Contactual Term Outstanding
Weighted Average Remaining Contactual Term Granted
Weighted Average Remaining Contactual Term Vested
Aggregate Intrinsic Value Outstanding, Ending
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value]
Weighted Average Exercise Price Outstanding, Beginning
Aggregate Intrinsic Value Granted
Aggregate Intrinsic Value Exercised
Aggregate Intrinsic Value Expired Or Forfeited
Aggregate Intrinsic Value Vested
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value]
Options Outstanding, Beginning
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]
Options Exercised
Options Granted
Options Expired Or Forfeited
Options Outstanding, Ending
Options Vested
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number]
Award Type [Axis]
Financial Instrument [Axis]
2018-ESOP
Option [Member]
2018-NQSOP
2021 Employee Stock Purchase Plan
Unrecognized Option Expense
Unrecognized Option Expense Period Of Recognition
Options To Acquire Shares Of Common Stock
Volatility Rate
Term
Discount Percentage
Stock Incentive Plan Description
Number Of Shares Of Common Stock Issued
Shares Price Per Shares
Options Exercisable Term Period
Vesting Period
Vesting Percentage
Warrants (Details Narrative)
Measurement Input Type [Axis]
Warrant [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Expected Term [Member]
Measurement Input, Discount Rate [Member]
Warrants, Volatility
Warrant Exercise Price
Number Of Warrant Purchase Common Stock
Warrants Outstanding
Warrants Outstanding, Term
Warrants, Term
Warrants, Discount Rate
Provision (benefit) At Statutory Rate
Permanent Differences
Temporary Differences
Change In Valuation Allowance
Deferred Tax Assets:
Net Operating Loss Carryforward
Other Assets
Deferred Tax Assets
Deferred Tax Liabilities:
Deferred Tax Liabilities
[Deferred Tax Liabilities, Net]
Net Deferred Tax Assets
Valuation Allowance
[Deferred Tax Assets, Valuation Allowance]
Net Operating Loss Carryforwards
U.s. Federal Income Tax, Rate
Office Space
Product Development Facility Area
Contract Amount For Construction In Progress
Outstanding Contract Amount For Construction In Progress
Monthly Salary
Monthly Salary Equivalent To Taiwan Dollors
Annual Compensation In The Form Of Cash Percentage Range
Vesting Stock Options
Bonus Of Shares
Warrants Issued
Non-convertible Note Issued Principal Amount
Converted Into Shares Of Common Stock
Conversion Price Of Per Share
Annual Salary
Shares Payable Quarterly Based On The Average Share Price
Principal And Accrued Interest Amount
Covid-19 Antigen Rapid Test Kits
Intellectual Property Assets Purchase Price
Convertible Promissory Note Principal Amount
Convertible Note Payable In Cash Date
Initial Public Offering Price Of The Offering Percentage
Unpaid Principal And Accrued Interest, And A Maturity Date
Unpaid Principal And Accrued Interest Rate
Non-convertible Note Issued Principal Amount
Unpaid Principal Amount
Accrued Interest
i2China Management Group LLC [Member]
8b.20 [Member]
9.21 [Member]
26.22[Member]
Total non-convertible notes payable
Total non-convertible notes payable accrued interest
Total non-convertible notes payable addition
Total convertible and non-convertible
Total convertible and non-convertible addition
Total convertible and non-convertible Payment
Total convertible and non-convertible accrued
Non-convertible notes payable-related party
Non-convertible notes payable-related party accrued interest
Non-convertible notes payable-related party addition
Accrued Interest
Due Date
Annual interest rate, From effective
Effective Date
Unpaid principal balance
Conversion rate
Payment
Addition
Conversion Note
Annual interest rate, Following maturity
consulting fee
Convertible and other notes payable- related parties
Accrued Interest- related parties
Total interest expense
Total Convertible and other notes payable
Cumulative related accrued interest
Principal amount
Convertible notes
Yun Han Liao [Member]
Chih Heng Tsai [Member]
Non-Current Convertible notes payable
Conversion Price Per Shares
Convertible Promissory Note
Convertible note issued